#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cold type haemolytic anaemia Renal cell carcinoma Cervix carcinoma recurrent Follicle centre lymphoma follicular grade I, II – III Arteriosclerosis Rosai-Dorfman syndrome Nodal marginal zone B-cell lymphoma Chorioretinitis ABO haemolytic disease of newborn Sickle cell disease Hypocalcaemia Glioblastoma Orthostatic hypotension Hypochondroplasia Leiomyosarcoma More trials…

    Learn about Rare Diseases

    IgA nephropathy Haemophilia B without inhibitors Cytokine release syndrome Hereditary hypophosphataemic rickets Primary biliary cholangitis – Trials in Disease Rhabdoid tumour – Trials in Disease Uterine leiomyosarcoma – Diagnostics Alport’s syndrome – Life with Disease Propionic acidaemia Haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Encorafenib Pyruvic Acid Magnesium Stearate Crgd-Zw800-1 Cinnarizine Artemisia Vulgaris (312) Bi 1839100 Tenofovir Disoproxil Midodrine Hydrochloride Litenimod Sodium Pabinafusp Alfa Gs-1427 SODIUM IBANDRONATE Thiamine Hydrochloride Irbesartan Cedazuridine Maralixibat Chloride AZD5335 Betaine Citrate Imidapril Hydrochloride More therapies…

    Learn about Your Condition

    Biliary tract operation Biliary cancer metastatic Bronchopulmonary aspergillosis Progressive supranuclear palsy Intestinal ischaemia Synovial sarcoma metastatic Nephrotic syndrome Hepatocellular carcinoma Urinary tract infection Heparin resistance Agitation postoperative Hyperplasia adrenal Cervix carcinoma stage II K-ras gene mutation Endotracheal intubation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on Edotreotide for Detecting Somatostatin Receptors in Patients with Metastatic Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Edotreotide
    France

  • Study on the Effects of R3R01 on Reducing Protein in Urine for Patients with Diabetic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Pentetic Acid
    • R3R01
    Denmark

  • Study on Patritumab Deruxtecan and Zirconium (89Zr) Patritumab Deruxtecan for Patients with Advanced EGFR Mutation Positive Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zirconium (89Zr) Patritumab Deruxtecan
    • Patritumab Deruxtecan
    The Netherlands

  • Study on Early Use of Norepinephrine vs. Standard Fluid Therapy in Emergency Department Patients with Hypotension or Shock

    Recruiting

    3 1 1 1
    Denmark Sweden

  • Study on Palonosetron and Netupitant for Preventing Nausea in Endometrial Cancer Patients Undergoing Taxane-Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Netupitant
    • Dexamethasone Phosphate
    • Palonosetron
    Italy

  • Study on Reducing or Stopping Immunosuppression with Tacrolimus and Ciclosporin in Patients with Late Kidney Transplant Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus
    Spain
Previous Page
1 … 8 9 10 11 12 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!